The day before yesterday, different groups and individuals intervened at the shareholders’ meeting of BAYER (the “most valuable” German company) in Cologne. On the page of the Coordination against BAYER Dangers some speeches can be found, including those held on behalf of glokal e.V. on“Profit in the slipstream of a population policy revival in international development policy” and on“Hormone implants and double standards in the global contraception market“.
On the occasion of tomorrow’s Annual Stockholders’ Meeting of Bayer, glokal e.V., together with the Gen-ethischen Netzwerk e.V., the BUKO Pharma-Kampagne and the Department of Development Policy and Postcolonial Studies at the University of Kassel, is protesting against the company’s worldwide marketing offensive with the hormone implant Jadelle.
of the Gen-ethischen Netzwerk e.V., glokal e.V., the BUKO Pharma-Kampagne as well as the Department of Development Policy and Postcolonial Studies of the University of Kassel
Bayer HealthCare’s Jadelle contraceptive implant: protest against population policy-motivated marketing offensive
Cologne, May 27, 2015: On the occasion of Bayer’s Annual Stockholders’ Meeting, non-governmental organizations and a university department in Kassel are protesting against the company’s global marketing offensive with the hormone implant Jadelle. The organizations, which will be present at the General Assembly with their own speeches, criticize frequent side effects and a subordination of reproductive health concerns to population policy goals. They are calling for a halt to the marketing of Jadelle as part of population policy programs. Continue reading